Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.

[1]  Xia Li,et al.  Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity , 2016, Nature Immunology.

[2]  E. Ballestar,et al.  IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation , 2016, Genome Biology.

[3]  Young-sil Yoon,et al.  CREB pathway links PGE2 signaling with macrophage polarization , 2015, Proceedings of the National Academy of Sciences.

[4]  M. Vetizou,et al.  Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells. , 2015, Cancer research.

[5]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. , 2015, The Journal of clinical investigation.

[6]  P. Arimondo,et al.  Design and synthesis of new non nucleoside inhibitors of DNMT3A. , 2015, Bioorganic & medicinal chemistry.

[7]  S. Ugel,et al.  Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. , 2015, The Journal of clinical investigation.

[8]  Yue Zhang,et al.  MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1 , 2015, The Journal of Immunology.

[9]  M. Nagarkatti,et al.  Δ9‐Tetrahydrocannabinol‐mediated epigenetic modifications elicit myeloid‐derived suppressor cell activation via STAT3/S100A8 , 2015, Journal of leukocyte biology.

[10]  Miao Yu,et al.  Bacterial infection remodels the DNA methylation landscape of human dendritic cells , 2015, bioRxiv.

[11]  Masaru Ishii,et al.  DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine–producing metabolic pathway , 2015, Nature Medicine.

[12]  David M. Woods,et al.  Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function. , 2015, Molecular immunology.

[13]  E. Ballestar,et al.  Epigenetic control of myeloid cell differentiation, identity and function , 2014, Nature Reviews Immunology.

[14]  M. Weirauch,et al.  DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells , 2014, Epigenetics & Chromatin.

[15]  E. Novellino,et al.  Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity , 2014, PloS one.

[16]  Q. Hu,et al.  Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. , 2013, The Journal of clinical investigation.

[17]  D. Aran,et al.  DNA Methylation of Transcriptional Enhancers and Cancer Predisposition , 2013, Cell.

[18]  A. Nicolaou,et al.  PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4). , 2013, Molecular immunology.

[19]  K. Odunsi,et al.  Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling , 2013, The Journal of experimental medicine.

[20]  Xiaoling Hu,et al.  Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer* , 2013, The Journal of Biological Chemistry.

[21]  Yulia Nefedova,et al.  Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer , 2012, Nature Immunology.

[22]  Steven K. Huang,et al.  Prostaglandin E2 increases fibroblast gene‐specific and global DNA methylation via increased DNA methyltransferase expression , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[24]  R. Edwards,et al.  Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. , 2011, Blood.

[25]  M. Lipp,et al.  Sphingosine‐1‐phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17‐cell differentiation in a murine model , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  A. Epstein,et al.  Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines , 2011, Journal of Translational Medicine.

[27]  Irving L. Weissman,et al.  A comprehensive methylome map of lineage commitment from hematopoietic progenitors , 2010, Nature.

[28]  L. Schwarzfischer,et al.  Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels , 2010, Genome Biology.

[29]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[30]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[31]  P. Sinha,et al.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. , 2007, Cancer research.

[32]  L. Nagy,et al.  Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. , 2007, Blood.

[33]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[34]  P. Kalinski,et al.  IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. , 1997, Journal of immunology.

[35]  M. Mielcarek,et al.  Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. , 1997, Blood.

[36]  C. Divino,et al.  Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. , 2010, Cancer research.

[37]  P. Sinha,et al.  Prostaglandin E 2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells , 2007 .